INTRODUCTION
A close association between platelets and neutrophils has been described at sites of inflammation and thrombosis [ 1-41. In such settings, bidirectional cellular interactions mediated by the release of soluble mediators and intercellular adhesion potentially modulate platelet and neutrophil functions. Previous studies in vitro have shown that activated neutrophils can enhance platelet thromboxane formation and 5hydroxytryptamine release as well as platelet aggregation , while activated platelets have been shown to adhere to neutrophils and stimulate superoxide production [8, 91. Other studies have demonstrated a co-dependency for plateletneutrophil metabolism of arachidonic acid metabolites such as platelet-activating factor (PAF) and leukotriene C4 [lo, 111 which are likely to further amplify the inflammatory and thrombotic responses in various disease states.
P-selectin is a membrane glycoprotein that is translocated to the surface of platelets after a-granule release in response to a variety of agonists including thrombin, PAF and collagen . Platelet P-selectin expression mediates platelet adhesion to neutrophils via interaction with one or more glycoproteins bearing sialylated, fucosylated lactosamine 0-linked oligosaccharides, such as sialyl Lewis", and expressed on the surface of neutrophils and monocytes [ 151. P-selectin glycoprotein ligand-1 (PSGL-1) is a quantitatively minor neutrophil glycoprotein that shows high-affinity binding to P-selectin by presenting <1% of the surface sialyl Lewis" [16, 171 . Previous studies have shown that the interaction between platelet P-selectin and its neutrophil counter-receptor(s) is critical in platelet-neutrophil binding and is likely to be important in promoting platelet-neutrophil interactions [18] [19] [20] [21] .
Although neutrophils produce a variety of inflammatory mediators including PAF, elastase and oxygen free radicals, platelet activation by neutrophils appears to be mainly mediated by the release of the neutrophil serine protease, cathepsin G [5-7, 20, 211 . This has been supported by studies demonstrating that purified cathepsin G induces platelet calcium mobilization, thromboxane formation, 5-hydroxytryptamine release and platelet aggregation as well as P-selectin expression [5] [6] [7] 221 . Therefore, platelets stimulated by cathepsin G released from activated neutrophils might be expected to adhere to neutrophils in a P-selectin-dependent manner. However, there is contrary evidence to suggest that activated neutrophils may actually inhibit plateletneutrophil adhesion and promote time-dependent dissociation of platelet-neutrophil aggregates [23] . Previous studies have shown that cathepsin G can cause extensive proteolysis of the glycoprotein GPlba subunit within the platelet GPlb-IX complex on the platelet surface [24, 251. A similar proteolytic effect of cathepsin G on P-selectin or its neutrophil ligand may explain the inhibition by activated neutrophils of platelet-neutrophil adhesion.
Therefore the aims of this study were first to compare the effects of supernatant from activated neutrophils, cathepsin G and thrombin on platelet P-selectin expression, and to determine the time course of these effects. The second aim was to determine whether neutrophil-derived cathepsin G inhibits P-selectin-mediated platelet-neutrophil adhesion or dissociates platelet-neutrophil aggregates via effects on platelet P-selectin or its neutrophi1 ligand.
METHODS

Materials
Cathepsin G, a1-antichymotrypsin, cytochalasin B and N-formyl-L-Met-L-Leu-L-Phe (fMLP) were purchased from Calbiochem, Sydney, Australia. Bovine serum albumin (BSA) was from CSL (Melbourne, Australia), phorbol 12-myristate 13-acetate (PMA) from Sigma Chemical Co. (Sydney, Australia), thrombin from Armour Pharmaceuticals Co. (Kankakee, IL, U.S.A.), and prostaglandin EI from Cayman Chemicals (Ann Arbor, MI, U.S.A.). Mouse isotype control IgGl-fluorescein isothiocyanate/ IgG2,-phycoerythrin (PE), PE-conjugated monoclonal antibodies to P-selectin (CD62P, IgGl isotype) and integrin (CDllb, IgGz, isotype) and unconjugated monoclonal antibody to sialyl Lewisx (IgM isotype, containing 0.01% azide) were purchased from Becton Dickinson, Rutherford, NJ, U.S.A.
Subjects and blood collection
Twenty-eight healthy subjects (14 males and 14 females), mean age 27.7(range 23-44) years, with no history of infection, trauma or use of medication, including aspirin, in the preceding 10 days, were recruited and each subject gave written informed consent. The study was approved by the Committee for Human Rights of the University of Western Australia. Blood was taken at 09.00 h with the subjects having fasted overnight and having undertaken no strenuous exertion that morning. Blood was collected from an antecubital vein without use of a tourniquet via a 19-gauge butterfly needle. The first 2ml was discarded, and 20ml was then drawn directly into acid-citrate-dextrose (1.5 m1/10 ml) tubes. A further 40ml of blood was drawn directly into heparin (1 i.u./ml) tubes.
Preparation of cells
Washed platelets. Whole blood anticoagulated with acid-citrate-dextrose was centrifuged (150 g, 12 min) and the resulting platelet-rich plasma was aspirated and washed with Tyrode's buffer (138 mmol/l NaCl, 29 mmol/l KCI, 12 mmolfl NaHC03, 0.4 mmolfl NaHP04, 5.5 mmol/l glucose, 0.35% (w/v) BSA, pH 6.5) containing 50 ng/ml prostaglandin El. After centrifugation (2000 g, 10 min) the platelet pellet was resuspended in Tyrode's buffer containing 2 mmolfl Ca2+. Platelets were counted, diluted to 25 x lo6 cells/ml in Hepesbuffered Hanks balanced salt solution (HBSS), pH 7.4, containing 0.25% (w/v) BSA and kept at room temperature.
Neutrophil suspension. Neutrophils were prepared from whole blood, anticoagulated with heparin, by centrifugation on discontinuous Percoll gradients [26] . After centrifugation (400g 30 min), plasma and lymphocytes were discarded and the neutrophil layer was aspirated. The cells were sedimented by centrifugation (400g 10 min) and erythrocytes in the pellet were lysed with hypotonic saline. Neutrophils were finally resuspended in Hepes/HBSS containing 2 mmolfl Ca2+ and 0.25% (w/v) BSA, counted and diluted to 25 x lo6 cells/ml. Neutrophil purity and viability were greater than 95% as determined by differential count (Coulter Counter) and Trypan Blue exclusion respectively.
Stimulation of platelet P-selectin expression by neutrophil supernatant
Cytochalasin B was used to prime neutrophils for fMLP-induced degranulation. The neutrophil suspension (0.4 ml, 25 x lo6 cells/ml) was incubated at room temperature with cytochalasin B ( 5 pg/ml) for 2 min followed by fMLP (10 pmolfl) for a further 5 min. Non-activated neutrophils were similarly incubated for a total of 7 rnin with buffer alone. The non-activated and activated neutrophil suspensions were centrifuged (400 g, 2 min) to sediment cells and obtain non-activated or activated supernatants respectively.
Washed platelet suspension (40 pl, 25 x lo6 cells/ ml) and neutrophil supernatant (40 pl of activated or non-activated supernatant) were incubated with buffer (10 pl) and a specific PE-labelled monoclonal antibody to P-selectin (10 pl, 1/40 dilution) for 40 min at room temperature before fixing with 0.5% (vhr) formaldehyde. PMA (10 pl, 1.6 pmol/l) or thrombin (10 pl, 0.01 i.u./ml) was added to separate tubes each containing washed platelets and the supernatant from non-activated neutrophils. PMA and thrombin served as positive controls and the concentrations used were the lowest that produced maximum platelet activation. In a similar set of experiments purified cathepsin G (0.1, 10 and 50 pg/ml) was incubated with washed platelet suspension for 40 min before fixation with formaldehyde and assessment of platelet P-selectin expression. To confirm that platelet P-selectin expression was induced by cathepsin G in activated neutrophil supernatants, El-antichymotrypsin, the specific human plasma inhibitor of serine proteases such as cathepsin G, was incubated for 10min at concentrations of 10, 50 and lOOpg/ml with activated neutrophil supernatant before the incubation with platelet suspension for 40 min. To determine the time course of the effect of cathepsin G on P-selectin expression, platelet activation by cathepsin G (50pg/ml) was stopped after 1, 10, 30, 60 and 120min, by the addition of 0.5% (vhr) formaldehyde before incubation with the labelled monoclonal antibody. Platelet P-selectin expression was also compared at the same time points in unstimulated platelets, after stimulation with thrombin (0.01 i.u./ml) alone, and after stimulation with thrombin for 10min followed by cathepsin G (50 pg/ml).
Adhesion of activated platelets to neutrophils in mixed cell suspensions
As neutrophils do not express P-selectin, the detection of this receptor on neutrophils served as an indirect measure of platelet adhesion to neutrophils. This was studied in mixed cell suspensions, adjusted to a constant platelet-neutrophil ratio of 10: 1, with the cells co-incubated for 10 min before stimulation with thrombin (0.01 i.u./ml). The samples were then incubated with the PE-labelled P-selectin-specific monoclonal antibody for 30 min at room temperature without stirring before fixing with 0.5% (vhr) formaldehyde. To determine whether thrombin-stimulated platelet adhesion to neutrophils was mediated by interaction of platelet P-selectin with sialyl Lewis" oligosaccharides on neutrophils, neutrophil suspensions were exposed to a specific monoclonal antibody to sialyl Lewis" at dilutions of 1/10, 1/50 and W O O for 20min, before incubation with the platelet suspension and stimulation with thrombin (0.01 i d m l ) .
In a further experiment to compare the time course of the effects of thrombin, cathepsin G, and cathepsin G after thrombin on platelet-neutrophil adhesion, the platelets in the mixed cell suspensions were left unstimulated or were stimulated with cathepsin G (50 pg/ml) alone, thrombin (0.01 i.u./ml) alone, or cathepsin G after 10 rnin of thrombin. The reactions were stopped after 1, 10, 30, 60 and 120 min by the addition of 0.5% (vhr) formaldehyde before incubation with the PE-labelled monoclonal antibody to P-selectin. Finally, to examine the possible effect of cathepsin G on sialyl Lewisx, neutrophils were incubated with cathepsin G (50 pg/ml) for 30min before incubation with the mouse, antihuman sialyl Lewis" monoclonal antibody followed by a fluorescein isothiocyanate-labelled anti-mouse Fc-specific antibody.
Flow cytometry
Platelet P-selectin expression was assessed by measuring the fluorescence of the PE-labelled P-selectin-specific monoclonal antibody using a FACScan flow cytometer (Becton Dickinson) [13, 14, 271 . The platelet population was identified by setting analytical gates on the basis of forward-and side-angle light scatter with data collected in log mode using single parameter analysis of 5000 platelets. Binding of the PE-labelled antibody to platelets was quantified as the percentage of platelets exhibiting PE fluorescence as well as the mean channel fluorescence (MCF). The relative density of P-selectin receptors per platelet was deemed to be directly proportional to the level of P-selectinspecific fluorescence per platelet. Therefore, the relative density of P-selectin receptors is expressed either as the relative specific fluorescence (RSF) or as MCF (in arbitrary units). The RSF was calculated from the formula: RSF = Antilog [(n -m)/channels per log] -1, where n is the MCF of platelets incubated with the test antibody and m is the MCF of platelets incubated with the negative control antibody [28] .
The level of platelet-neutrophil adhesion was determined by flow cytometry using anti-P-selectin rather than anti-GPIIb-IIIa as a platelet marker [19] . In brief, for selected samples the neutrophil population was gated on the basis of its characteristic forward-and side-scatter profile and expression of the integrin, C D l l b (present on neutrophils, monocytes and natural killer lymphocytes) on at least 99% of cells as determined by a specific PE-labelled monoclonal antibody. The percentage of neutrophils positive for platelet P-selectin fluorescence was taken as an estimate of the percentage of neutrophils with at least one bound platelet [19] .
The MCF of the platelet marker on neutrophils was also determined as this has been shown to correspond semi-quantitatively to the number of platelets bound per neutrophil [19] and also provides an indication of the degree of activation of the platelets bound to neutrophils. Activated platelets and neutrophils were co-incubated before addition of the anti-P-selectin, thus minimizing the possibility that the antibody would interfere with platelet-neutrophi1 binding. However, it was possible that this method would underestimate platelet-neutrophil binding because P-selectin molecules involved in binding to neutrophils would be inaccessible to the PE-labelled antibody. Nevertheless, this does not appear to have been a significant problem, since the levels of thrombin-induced platelet-neutrophil adhesion (60-80% P-selectin-positive neutrophils) were very similar to those observed in other studies using GPIIb-IIIa or GPIb as markers of adhesion [19, 231, indicating that P-selectin is also a valid marker of platelet-neutrophil adhesion.
Statistical analysis
Data for the percentage positive cells, the RSF and MCF were expressed as means_+S.E.M. For multiple comparisons, analysis of variance was used and where significant differences were identified (P< 0.05), painvise comparisons were made using Tukey's multiple comparison test (Instat 2 programme, GraphPad, San Diego, CA, U.S.A.).
RESULTS
Effects of neutrophil supernatant and cathepsin G on platelet P-selectin expression
After incubation with the supernatant from nonactivated neutrophils, platelet P-selectin expression was 28 f 4%, while the supernatant from fMLP/cytochalasin B-activated neutrophils induced P-selectin expression on 59+5% of cells ( P <0.001, n = 14). The latter response was approximately 70% of the maximum platelet P-selectin expression induced by PMA (84f3%) and thrombin (79$_5%) ( Figure  la) . Purified cathepsin G also produced a dosedependent platelet activation, with concentrations of 10 and 50 pg/ml producing a significant increase in the percentage of platelets expressing P-selectin ( P <0.01 and P<O.OOl compared with baseline respectively, n = 8, Figure lb) . The supernatant from activated neutrophils produced approximately 70% of the platelet P-selectin expression induced by the highest concentration of cathepsin G (50 pg/ml). Although the supernatant from activated neutrophils, like thrombin, produced significant platelet activation at 40min as determined by the percentage of platelets expressing P-selectin, the relative number of receptors per cell, as indicated by the RSF, was only 35+6% of the RSF for thrombinstimulated platelets (P<O.OOl, n = 14). Similar results were obtained with cathepsin G (50 pg/ml) which produced a significant increase in the percentage of platelets expressing P-selectin whereas the RSF per cell after stimulation with cathepsin G for 40 min was only 20+4% of that for thrombin-stimulated platelets (P<O.OOl, n = 6).
Effect of a I -antichymotrypsin on platelet P-selectin expression induced by cathepsin G and neutrophil Supernatant
The specific cathepsin G inhibitor, al-antichymotrypsin, produced a dose-dependent inhibition of platelet P-selectin expression induced by purified cathepsin G (50 pg/ml) with significant inhibition at 100 pg/ml al-antichymotrypsin ( P <0.001, n = 8, Figure 2a) . Equally, at concentrations of 50 and 100 pg/ml, al-antichymotrypsin completely inhibited platelet P-selectin expression induced by the supernatant from activated neutrophils (P<O.Ol, n = 8, Figure 2b ), indicating that stimulation of platelet P-selectin expression by neutrophil supernatant was likely to have been mediated by cathepsin G.
Time course of the effects of thrombin and cathepsin G on platelet P-selectin expression
In non-stimulated platelets, P-selectin expression did not change significantly at 1, 10, 30, 60 or 120 min, whereas within 10 rnin thrombin produced maximum platelet activation in terms of percentage of platelets expressing P-selectin and MCF, and there was no subsequent decline in the number of platelets expressing P-selectin or in the MCF up to 120min post stimulation (Figure 3 ). In the first 10 rnin of stimulation, cathepsin G also increased the percentage and MCF of platelets expressing P-selectin to levels similar to that seen with thrombin. However, unlike thrombin, there was a significant decline in percentage and MCF of platelets expressing P-selectin within 30 rnin of stimulation with cathepsin G, which declined further to baseline levels by 60 rnin (P<O.OOl compared with 10 min, n = 6). When platelet P-selectin was maximally expressed after 10 min of thrombin stimulation, the addition of cathepsin G produced a similar progressive decline in percentage and MCF of P-selectinpositive platelets, falling to near baseline levels at 60 min (P<O.OOl compared with 10 min, n = 6). 
FB. 4. Effect of thrombin on platelet adhesion to neutrophils. The
percentage of neutrophils exhibiting P-selectin-specific fluorescence after cc-incubation with non-activated platelets (0) or platelets stimulated with thrombin (0.01 i.u./ml) in the presence of increasing concentrations of a specific anti-sialyl Lewis" monoclonal a n t i q (0) (n = 6). *P<O.OI and "P<O.OOI compared with no antibody.
Effect of thrombin on platelet adhesion to neutrophils
Thrombin stimulation of platelets co-incubated for 40 min with neutrophils resulted in a significant increase in platelet P-selectin-specific fluorescence on neutrophils, rising from a baseline of 24+7% with unstimulated platelets to 56 k 10% with thrombin-stimulated platelets (P<O.O01, n = 6, Figure 4) . The thrombin-stimulated platelet P-selectin fluorescence on neutrophils was completely inhibited by preincubation of the neutrophils with a specific monoclonal antibody directed at the sialyl Lewis" oligosaccharides on the neutrophil surface (P<O.OOl, n = 6, Figure 4 ).
Time course of the effects of thrombin and cathepsin G on platelet-neutrophil adhesion
When incubated with non-stimulated platelets, the percentage of neutrophils exhibiting platelet P-selectin fluorescence increased to 20% at 10 min and did not change thereafter. In contrast, stimulation of platelets with thrombin in a mixed cell suspension of platelets and neutrophils produced a significant increase in the percentage and MCF of neutrophils exhibiting platelet P-selectin-specific fluorescence (P<0.001, n = 7, Figure 5 ). The increased platelet-neutrophil adhesion occurred within 1 min of thrombin stimulation, reached a maximum by 10min and did not decline over 120 min. This corresponded to the time course of the effect of thrombin on P-selectin expression in the washed platelet suspension (Figure 3 ). In contrast, cathepsin G stimulation of platelets in the mixed cell suspension produced no increase in platelet-neutrophil adhesion over 120 min, and in fact the percentage of neutrophils expressing platelet P-selectin fluorescence was significantly below baseline levels 120 min after cathepsin G stimulation (Pc0.05, Figure 5a ). The lack of increased plateletneutrophil binding after cathepsin G was discordant with the increased platelet P-selectin expression induced by cathepsin G in the washed platelet suspension within the first 10 min of stimulation (Figure 3) . Similarly, in a mixed cell suspension, when platelet-neutrophil adhesion was induced by thrombin, subsequent addition of cathepsin G caused a significant decrease in the percentage and MCF of neutrophils expressing platelet-specific P-selectin by 30-60 rnin (P<O.OOl, n = 7, Figure 5) , indicating dissociation of platelet-neutrophil aggregates. Cathepsin G had no effect on the percentage of neutrophils expressing sialyl Lewis" (95 2% without cathepsin G compared with 94*3% after incubation with cathepsin G, n = 4).
DISCUSSION
Platelet activation by neutrophil-derived cathepsin G has been proposed as a mechanism by which neutrophils are involved in thrombosis and can recruit and activate platelets in inflammatory disease [l, 2, 211. In support of this, we have shown that the supernatant from neutrophils activated with fMLP/ cytochalasin B produced a significant increase in the percentage of platelets expressing P-selectin, indicating significant platelet activation and a-granule release. P-selectin expression on approximately 20% of unstimulated platelets appears to be an inevitable consequence of activation during preparation. However, the results suggest that this basal activation does not affect platelet responses to PMA, thrombin and cathepsin G which were close to maximum. Furthermore, the variation in mean basal P-selectin expression in different experiments would not influence the relative differences in stimulated P-selectin expression within a given experiment.
The supernatant from activated neutrophils induced platelet P-selectin expression equivalent to 70% of that induced by the highest concentration of pure cathepsin G (50pg/ml) in the same experimental system. Although previous studies have suggested that cathepsin G concentrations of 0-10 pg/ ml are within the physiological range [5, 6, 221 , the results from this study suggest that local concentrations produced endogenously by degranulating neutrophils at sites of inflammation could be much greater. Alphal-antichymotrypsin, present in human plasma, is the most potent and specific inhibitor of cathepsin G, and in this experimental model caused complete inhibition of platelet P-selectin expression induced by neutrophil supernatant, suggesting that cathepsin G released by activated neutrophils was the primary stimulus for platelet activation and P-selectin expression. Other investigators, however, have shown that elastase, released with cathepsin G from neutrophil azurophilic granules, can potentiate cathepsin G-induced platelet activation, although it does not directly stimulate platelets and is not inhibited by a\-antichymotrypsin [29] .
A new and potentially important finding in this study was that, although activated neutrophil supernatant and purified cathepsin G induced expression of P-selectin on a high percentage of platelets, the relative receptor density per cell was low, being only 20-35% of that seen after 40min of thrombin stimulation. Investigation of the time course of the effect of cathepsin G on platelet P-selectin expression revealed that within the first 10 min, cathepsin G increased the MCF and percentage of platelets expressing P-selectin to a level equivalent to that observed after thrombin stimulation, but unlike thrombin there was a subsequent decline in P-selectin expression over 30-60 min to baseline levels. A previous study of the effect of purified cathepsin G on P-selectin fluorescence over 30 min may not have detected a significant decline in P-selectin expression [22] because in the present study the cathepsin G-induced loss of P-selectin was most marked after 30-60 min. These results would be consistent with proteolytic cleavage by cathepsin G of P-selectin or at least the epitope recognized by the P-selectin-specific monoclonal antibody, although it is possible that cathepsin G may be causing a conformational change of the P-selectin molecule. Cathepsin G induced a rapid loss of P-selectin expression on platelets which had been maximally prestimulated with thrombin, and again this is consistent with a proteolytic effect of cathepsin G on P-selectin. In support of this, cathepsin G has been shown to cleave the von Willebrand factor binding site at the L e~~~~-T y r~~~ peptide bond of the GPlba subunit of the GPlb-IX complex [25, 301, to produce conformational changes in the fibrinogen binding site of GPIIb-IIIa [24] and to cleave the N-terminus of a separate protease-activated platelet receptor for thrombin at A~-g~' -S e r~~ and at Phe55-Trp56 [31]. P-selectin, like GPlba, is a heavily glycosylated protein with N-terminal extracellular lectin and epidermal growth factor domains [15] and it is quite likely to also contain one or more sites that are susceptible to cleavage by cathepsin G.
Platelet adhesion to neutrophils facilitates neutrophi1 superoxide production [8, 91 and transcellular metabolism of arachidonic acid and PAF [lo, 111. Close platelet-neutrophil contact may also create a microenvironment in which neutrophil-derived cathepsin G is protected from inactivation by antiproteinases in plasma [7] . In this study the ratio of platelets to neutrophils (10: 1) was chosen to simulate that likely to occur at sites of inflammation rather than the higher ratio found in blood, although other studies using whole blood [19] or a platelet-neutrophi1 ratio of 100: 1 [23] found similar levels of platelet-neutrophil adhesion to those observed in the present study. Thrombin increased platelet P-selectin expression and induced a high and sustained level of platelet adhesion to non-activated neutrophils, as demonstrated by platelet-specific P-selectin fluorescence on neutrophils. Although previous studies have shown that P-selectin is critical to binding of activated platelets to neutrophils and monocytes [18-201 the nature of the ligand(s) for P-selectin on the neutrophil surface has been less clear [16] . This study provides further evidence supporting the importance of sialyl Lewis" as a component of the neutrophil ligand for P-selectin by demonstrating complete inhibition of thrombinstimulated platelet adhesion to neutrophils with a saturating concentration of anti-sialyl Lewis" monoclonal antibody. Recent studies suggest that the glycoprotein PSGL-1 is likely to be the sialyl Lewis"-bearing ligand on neutrophils that binds with high affinity to P-selectin [15, 161.
The time course of platelet-neutrophil adhesion after thrombin stimulation closely followed the thrombin-induced increase in platelet P-selectin expression. In contrast, the effect of cathepsin G was significantly different with no associated increase in platelet-neutrophil adhesion through 120 min of co-incubation. Furthermore, when platelet-neutrophil adhesion was induced by thrombin, cathepsin G caused dissociation of platelet-neutrophi1 aggregates. The inhibition of platelet-neutrophi1 adhesion by cathepsin G cannot be explained by loss of platelet P-selectin expression since there was no adhesion even before the reduction in P-selectin expression at 30 min. The explanation proposed by Rinder et al.
[23] for their similar observation that neutrophil activation by fMLP inhibited P-selectinmediated platelet-neutrophil adhesion was that neutrophil activation decreases the expression of the neutrophil ligand for P-selectin. However, similar activation of monocytes did not result in inhibition of monocyte-platelet adhesion, suggesting that neutrophil, but not monocyte, activation causes release of a product such as cathepsin G that modifies the P-selectin ligand on neutrophils [23]. In another study, cathepsin G was shown to inhibit E-selectin-mediated neutrophil adhesion to endothelial cells by a mechanism that did not involve cleavage of neutrophil L-selectin or modification of CDl lb/CD18 expression [32] . However, other studies have suggested that neutrophil release products may cause degradation or redistribution of the P-selectin ligand on neutrophils [33-351. In the present study, we were unable to demonstrate any reduction in sialyl LewisX expression on neutrophils after 30min of incubation with cathepsin G. However, it is possible that cathepsin G either cleaves or modifies the polypeptide backbone of the P-selectin ligand PSGL-1. Any resulting loss of sialyl LewisX moieties would be insignificant relative to the total amount of this oligosaccharide present on neutrophils but high-affinity binding of P-selectin to sialyl Lewis" on PSGL-1 may well be disrupted. Thus, the precise mechanism for the lack of platelet neutrophi1 adhesion after stimulation by cathepsin G remains uncertain, but it seems likely that it involves an effect of cathepsin G on the neutrophil P-selectin ligand.
In summary, our investigations provide further insight into a complex rangc of platelet-neutrophil interactions that have been observed in vifro. This study has shown that cathepsin G released from activated neutrophils stimulates platelet activation with initial P-selectin expression, followed by a loss of P-selectin possibly due to the proteolytic effect of cathepsin G. This neutrophil-derived protease also inhibits platelet-neutrophil adhesion and can promote dissociation of platelet-neutrophil aggregates, but this effect may be due to the action of cathepsin G on the neutrophil P-selectin ligand. Although we can only speculate on the in vivo implications of our findings, the potential consequences of thrombin generation at sites of vascular injury may be to promote platelet adhesion to neutrophils, and thrombosis through platelet-leucocyte interactions. In predominantly inflammatory states, however, the balance may be towards neutrophil activation with release of cathepsin G, platelet activation, release of inflammatory mediators and platelet aggregation while subsequently inhibiting platelet-neutrophil adhesion.
